Heterogeneous Sensitivity to Src Inhibitors in Oral Squamous Cell Carcinoma and Its Implications for Combination Therapy with Cisplatin
Yuri Ofusa, Tadahide Noguchi, Hiroaki Mizukami, Kenji Ohba
This study evaluates Src inhibitor efficacy in OSCC cell lines and shows additive effects with cisplatin, enabling reduced cisplatin doses.
bioRxiv · Aug 31, 2026 · PreprintCancer Biology